Filing Details
- Accession Number:
- 0001127602-13-020031
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-06-11 15:55:00
- Reporting Period:
- 2013-06-10
- Filing Date:
- 2013-06-11
- Accepted Time:
- 2013-06-11 15:55:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875045 | Biogen Idec Inc. | BIIB | Biological Products, (No Disgnostic Substances) (2836) | 330112644 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1236534 | Lynn Schenk | Biogen Idec Inc. 133 Boston Post Road Weston MA 02493 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2013-06-10 | 1,000 | $225.96 | 3,920 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-06-10 | 1,000 | $225.67 | 2,920 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 7,100 | Indirect | By Trust |
Footnotes
- Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
- This represents the weighted average price of shares sold at a range between $225.79 (low) and $226.11 (high).
- Full information regarding the number of shares sold at each separate price will be provided upon request by the SEC staff, the issuer, or a security holder of the issuer.
- This represents the weighted average price of shares sold at a range between $225.42 (low) and $225.74 (high).
Billionaire Hedge Funds
